Cyxone Switzerland ^Company

Cyxone AB is a clinical biotech company with a portfolio of immunomodulating drugs for the treatment of autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis (RA). Cyxone Switzerland AG develops and commercialize pharmaceutical products as well as biomedical and diagnostic research and development.